Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program
Wendy C. Moore(Children's Hospital Colorado), Sally E. Wenzel(National Jewish Health), Mario Castro(University of Kansas Medical Center), William J. Calhoun(Cleveland Clinic), Kian Fan Chung(Imperial College London), Anne M. Fitzpatrick(Emory University), William W. Busse(University of Wisconsin–Madison), Elliot Israel(Brigham and Women's Hospital), Stephen P. Peters(Wake Forest University), Eugene R. Bleecker(Mayo Clinic in Arizona), Bruce D. Levy(Brigham and Women's Hospital), Leonard B. Bacharier(Washington University in St. Louis), Deborah A. Meyers(University of Arizona), W. Gerald Teague(University of Virginia), Bill T. Ameredes(National Institutes of Health), Douglas Curran‐Everett(Institute for Medical Informatics and Biostatistics), Mark Hew(Monash Health), Benjamin Gaston(National Institutes of Health), Iftikhar Hussain(National Institutes of Health), Melissa P. Clark(National Institutes of Health), James R. Murphy(University of Liverpool), Nizar N. Jarjour(University of Wisconsin–Madison), Raed A. Dweik(Cleveland Clinic), Serpil C. Erzurum(Mayo Clinic in Arizona)
Cited by 933
Related Papers
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
|European Respiratory Journal|2013|3.9k
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report
|Journal of Allergy and Clinical Immunology|2010|2.3k
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
|New England Journal of Medicine|2018|1.9k
Genetic Epidemiology of COPD (COPDGene) Study Design
|COPD Journal of Chronic Obstructive Pulmonary Disease|2010|1.3k
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
|Journal of Allergy and Clinical Immunology|2001|1.3k